Evidence of Chronic Damage to the Pulmonary Microcirculation in Habitual Users of Alkaloidal (“Crack”) Cocaine
To evaluate BAL cells obtained from habitual users of alkaloidal (“crack”) cocaine alone or in combination with tobacco, for evidence of cocaine-associated alveolar injury. Prospective cohort study. A total of 36 healthy men and women (mean age [SD], 37.5 [7.5] years), including 10 cocaine-only smok...
Gespeichert in:
Veröffentlicht in: | Chest 2002-04, Vol.121 (4), p.1231-1238 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1238 |
---|---|
container_issue | 4 |
container_start_page | 1231 |
container_title | Chest |
container_volume | 121 |
creator | Baldwin, Gayle Cocita Choi, Ruth Roth, Michael D. Shay, Angela H. Kleerup, Eric C. Simmons, Michael S. Tashkin, Donald P. |
description | To evaluate BAL cells obtained from habitual users of alkaloidal (“crack”) cocaine alone or in combination with tobacco, for evidence of cocaine-associated alveolar injury.
Prospective cohort study.
A total of 36 healthy men and women (mean age [SD], 37.5 [7.5] years), including 10 cocaine-only smokers (CS), 6 cocaine-plus-tobacco smokers (CTS), 10 tobacco smokers (TS), and 10 nonsmokers (NS), underwent fiberoptic bronchoscopy and BAL.
Cytospins were prepared from BAL cells and stained with Wright-Giemsa for cell differentials and Gomori's stain for detection of hemosiderin. Endothelin (ET)-1 levels were determined from lavage fluid by enzyme-linked immunosorbent assay.
None of the cocaine users reported episodes of hemoptysis or respiratory distress, and routine spirometry findings were within normal limits in all subjects. While there was little effect on total cell numbers or differential counts, the percentages of hemosiderin-positive alveolar macrophages (AMs) were markedly increased in CS (33.8 ± 8.7% [SEM]) compared to TS and NS (< 2%; p < 0.05). The percentages of hemosiderin-laden AMs were also numerically increased in CTS (11.8 ± 7.8%), but this value was not statistically significant from that of TS or NS. ET-1 levels were significantly increased in the fluid recovered from CS (6.2 ± 0.8 pg/mL) when compared to NS (1.2 ± 0.4 pg/mL) and TS (1.3 ± 0.2 pg/mL) [p < 0.05], while ET-1 levels were elevated to a lesser extent in CTS (2.5 ± 0.6 pg/mL). ET-1 levels correlated with the percentage of hemosiderin-positive AMs when CS were analyzed in conjunction with CTS (r = 0.64; p = 0.0004).
Clinically inapparent alveolar hemorrhage occurs frequently in otherwise healthy crack cocaine smokers and is associated with elevated levels of ET-1, indicative of cocaine-induced pulmonary microvascular injury. |
doi_str_mv | 10.1378/chest.121.4.1231 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_200412000</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0012369215343051</els_id><sourcerecordid>118919489</sourcerecordid><originalsourceid>FETCH-LOGICAL-c444t-f684b5e9b0f91e94ac11d60f3b920b869f61131f21a1dac7d4be5f548a7308263</originalsourceid><addsrcrecordid>eNp1Uc1u1DAQthCIbgt3TshCQiqHLJ7YySbcqlBapCI40LM1cezGrRMXOyni1geBl-uT1MtGWnHgMiOPvp-Zz4S8ArYGvqneq17HaQ05rEWqHJ6QFdQcMl4I_pSsGIM842WdH5DDGK9ZekNdPicHqYmKFdWKhNM72-lRaeoNbfrgR6voRxzwStPJ06nX9NvsBj9i-EW_WBW8skHNDifrR2pHeo6tnWZ09DLqELcqJ-4Gnbddmh0_3P9uAqqbh_s_72jjFdpRvyDPDLqoXy79iFx-Ov3enGcXX88-NycXmRJCTJkpK9EWum6ZqUHXAhVAVzLD2zpnbVXWpgTgYHJA6FBtOtHqwhSiwg1nVV7yI_Jmp3sb_I85BSWv_RzGZClzxgSkwhKI7UDpshiDNvI22CEdK4HJbcbyb8YyZSyF3GacKK8X3bkddLcnLKEmwNsFgFGhMwFHZeMex0tei2Kz9-7tVf_TBi3jgM4lWb5zXfb9x_vDjqJTcHdWBxmV3X5fl-hqkp23_1_8EWJ9q5g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200412000</pqid></control><display><type>article</type><title>Evidence of Chronic Damage to the Pulmonary Microcirculation in Habitual Users of Alkaloidal (“Crack”) Cocaine</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Baldwin, Gayle Cocita ; Choi, Ruth ; Roth, Michael D. ; Shay, Angela H. ; Kleerup, Eric C. ; Simmons, Michael S. ; Tashkin, Donald P.</creator><creatorcontrib>Baldwin, Gayle Cocita ; Choi, Ruth ; Roth, Michael D. ; Shay, Angela H. ; Kleerup, Eric C. ; Simmons, Michael S. ; Tashkin, Donald P.</creatorcontrib><description>To evaluate BAL cells obtained from habitual users of alkaloidal (“crack”) cocaine alone or in combination with tobacco, for evidence of cocaine-associated alveolar injury.
Prospective cohort study.
A total of 36 healthy men and women (mean age [SD], 37.5 [7.5] years), including 10 cocaine-only smokers (CS), 6 cocaine-plus-tobacco smokers (CTS), 10 tobacco smokers (TS), and 10 nonsmokers (NS), underwent fiberoptic bronchoscopy and BAL.
Cytospins were prepared from BAL cells and stained with Wright-Giemsa for cell differentials and Gomori's stain for detection of hemosiderin. Endothelin (ET)-1 levels were determined from lavage fluid by enzyme-linked immunosorbent assay.
None of the cocaine users reported episodes of hemoptysis or respiratory distress, and routine spirometry findings were within normal limits in all subjects. While there was little effect on total cell numbers or differential counts, the percentages of hemosiderin-positive alveolar macrophages (AMs) were markedly increased in CS (33.8 ± 8.7% [SEM]) compared to TS and NS (< 2%; p < 0.05). The percentages of hemosiderin-laden AMs were also numerically increased in CTS (11.8 ± 7.8%), but this value was not statistically significant from that of TS or NS. ET-1 levels were significantly increased in the fluid recovered from CS (6.2 ± 0.8 pg/mL) when compared to NS (1.2 ± 0.4 pg/mL) and TS (1.3 ± 0.2 pg/mL) [p < 0.05], while ET-1 levels were elevated to a lesser extent in CTS (2.5 ± 0.6 pg/mL). ET-1 levels correlated with the percentage of hemosiderin-positive AMs when CS were analyzed in conjunction with CTS (r = 0.64; p = 0.0004).
Clinically inapparent alveolar hemorrhage occurs frequently in otherwise healthy crack cocaine smokers and is associated with elevated levels of ET-1, indicative of cocaine-induced pulmonary microvascular injury.</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1378/chest.121.4.1231</identifier><identifier>PMID: 11948058</identifier><identifier>CODEN: CHETBF</identifier><language>eng</language><publisher>Northbrook, IL: Elsevier Inc</publisher><subject>Adult ; Biological and medical sciences ; Bronchoalveolar Lavage Fluid - cytology ; Bronchoscopy ; Cell Count ; Cocaine ; Cocaine-Related Disorders - physiopathology ; Crack Cocaine - adverse effects ; Drug addictions ; endothelin-1 ; Enzymes ; Female ; Hemoptysis ; Hemorrhage ; Hemorrhage - chemically induced ; Hemorrhage - physiopathology ; hemosiderin ; Hemosiderin - metabolism ; Humans ; Lung - blood supply ; macrophages ; Macrophages, Alveolar - cytology ; Male ; Medical sciences ; Microcirculation - drug effects ; Microcirculation - physiopathology ; microvasculature ; Middle Aged ; pulmonary ; Pulmonary Disease, Chronic Obstructive - chemically induced ; Pulmonary Disease, Chronic Obstructive - physiopathology ; Risk Factors ; Smoking ; Tobacco ; Toxicology</subject><ispartof>Chest, 2002-04, Vol.121 (4), p.1231-1238</ispartof><rights>2002 The American College of Chest Physicians</rights><rights>2002 INIST-CNRS</rights><rights>Copyright American College of Chest Physicians Apr 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c444t-f684b5e9b0f91e94ac11d60f3b920b869f61131f21a1dac7d4be5f548a7308263</citedby><cites>FETCH-LOGICAL-c444t-f684b5e9b0f91e94ac11d60f3b920b869f61131f21a1dac7d4be5f548a7308263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13639457$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11948058$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baldwin, Gayle Cocita</creatorcontrib><creatorcontrib>Choi, Ruth</creatorcontrib><creatorcontrib>Roth, Michael D.</creatorcontrib><creatorcontrib>Shay, Angela H.</creatorcontrib><creatorcontrib>Kleerup, Eric C.</creatorcontrib><creatorcontrib>Simmons, Michael S.</creatorcontrib><creatorcontrib>Tashkin, Donald P.</creatorcontrib><title>Evidence of Chronic Damage to the Pulmonary Microcirculation in Habitual Users of Alkaloidal (“Crack”) Cocaine</title><title>Chest</title><addtitle>Chest</addtitle><description>To evaluate BAL cells obtained from habitual users of alkaloidal (“crack”) cocaine alone or in combination with tobacco, for evidence of cocaine-associated alveolar injury.
Prospective cohort study.
A total of 36 healthy men and women (mean age [SD], 37.5 [7.5] years), including 10 cocaine-only smokers (CS), 6 cocaine-plus-tobacco smokers (CTS), 10 tobacco smokers (TS), and 10 nonsmokers (NS), underwent fiberoptic bronchoscopy and BAL.
Cytospins were prepared from BAL cells and stained with Wright-Giemsa for cell differentials and Gomori's stain for detection of hemosiderin. Endothelin (ET)-1 levels were determined from lavage fluid by enzyme-linked immunosorbent assay.
None of the cocaine users reported episodes of hemoptysis or respiratory distress, and routine spirometry findings were within normal limits in all subjects. While there was little effect on total cell numbers or differential counts, the percentages of hemosiderin-positive alveolar macrophages (AMs) were markedly increased in CS (33.8 ± 8.7% [SEM]) compared to TS and NS (< 2%; p < 0.05). The percentages of hemosiderin-laden AMs were also numerically increased in CTS (11.8 ± 7.8%), but this value was not statistically significant from that of TS or NS. ET-1 levels were significantly increased in the fluid recovered from CS (6.2 ± 0.8 pg/mL) when compared to NS (1.2 ± 0.4 pg/mL) and TS (1.3 ± 0.2 pg/mL) [p < 0.05], while ET-1 levels were elevated to a lesser extent in CTS (2.5 ± 0.6 pg/mL). ET-1 levels correlated with the percentage of hemosiderin-positive AMs when CS were analyzed in conjunction with CTS (r = 0.64; p = 0.0004).
Clinically inapparent alveolar hemorrhage occurs frequently in otherwise healthy crack cocaine smokers and is associated with elevated levels of ET-1, indicative of cocaine-induced pulmonary microvascular injury.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Bronchoalveolar Lavage Fluid - cytology</subject><subject>Bronchoscopy</subject><subject>Cell Count</subject><subject>Cocaine</subject><subject>Cocaine-Related Disorders - physiopathology</subject><subject>Crack Cocaine - adverse effects</subject><subject>Drug addictions</subject><subject>endothelin-1</subject><subject>Enzymes</subject><subject>Female</subject><subject>Hemoptysis</subject><subject>Hemorrhage</subject><subject>Hemorrhage - chemically induced</subject><subject>Hemorrhage - physiopathology</subject><subject>hemosiderin</subject><subject>Hemosiderin - metabolism</subject><subject>Humans</subject><subject>Lung - blood supply</subject><subject>macrophages</subject><subject>Macrophages, Alveolar - cytology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microcirculation - drug effects</subject><subject>Microcirculation - physiopathology</subject><subject>microvasculature</subject><subject>Middle Aged</subject><subject>pulmonary</subject><subject>Pulmonary Disease, Chronic Obstructive - chemically induced</subject><subject>Pulmonary Disease, Chronic Obstructive - physiopathology</subject><subject>Risk Factors</subject><subject>Smoking</subject><subject>Tobacco</subject><subject>Toxicology</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1Uc1u1DAQthCIbgt3TshCQiqHLJ7YySbcqlBapCI40LM1cezGrRMXOyni1geBl-uT1MtGWnHgMiOPvp-Zz4S8ArYGvqneq17HaQ05rEWqHJ6QFdQcMl4I_pSsGIM842WdH5DDGK9ZekNdPicHqYmKFdWKhNM72-lRaeoNbfrgR6voRxzwStPJ06nX9NvsBj9i-EW_WBW8skHNDifrR2pHeo6tnWZ09DLqELcqJ-4Gnbddmh0_3P9uAqqbh_s_72jjFdpRvyDPDLqoXy79iFx-Ov3enGcXX88-NycXmRJCTJkpK9EWum6ZqUHXAhVAVzLD2zpnbVXWpgTgYHJA6FBtOtHqwhSiwg1nVV7yI_Jmp3sb_I85BSWv_RzGZClzxgSkwhKI7UDpshiDNvI22CEdK4HJbcbyb8YyZSyF3GacKK8X3bkddLcnLKEmwNsFgFGhMwFHZeMex0tei2Kz9-7tVf_TBi3jgM4lWb5zXfb9x_vDjqJTcHdWBxmV3X5fl-hqkp23_1_8EWJ9q5g</recordid><startdate>20020401</startdate><enddate>20020401</enddate><creator>Baldwin, Gayle Cocita</creator><creator>Choi, Ruth</creator><creator>Roth, Michael D.</creator><creator>Shay, Angela H.</creator><creator>Kleerup, Eric C.</creator><creator>Simmons, Michael S.</creator><creator>Tashkin, Donald P.</creator><general>Elsevier Inc</general><general>American College of Chest Physicians</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20020401</creationdate><title>Evidence of Chronic Damage to the Pulmonary Microcirculation in Habitual Users of Alkaloidal (“Crack”) Cocaine</title><author>Baldwin, Gayle Cocita ; Choi, Ruth ; Roth, Michael D. ; Shay, Angela H. ; Kleerup, Eric C. ; Simmons, Michael S. ; Tashkin, Donald P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c444t-f684b5e9b0f91e94ac11d60f3b920b869f61131f21a1dac7d4be5f548a7308263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Bronchoalveolar Lavage Fluid - cytology</topic><topic>Bronchoscopy</topic><topic>Cell Count</topic><topic>Cocaine</topic><topic>Cocaine-Related Disorders - physiopathology</topic><topic>Crack Cocaine - adverse effects</topic><topic>Drug addictions</topic><topic>endothelin-1</topic><topic>Enzymes</topic><topic>Female</topic><topic>Hemoptysis</topic><topic>Hemorrhage</topic><topic>Hemorrhage - chemically induced</topic><topic>Hemorrhage - physiopathology</topic><topic>hemosiderin</topic><topic>Hemosiderin - metabolism</topic><topic>Humans</topic><topic>Lung - blood supply</topic><topic>macrophages</topic><topic>Macrophages, Alveolar - cytology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microcirculation - drug effects</topic><topic>Microcirculation - physiopathology</topic><topic>microvasculature</topic><topic>Middle Aged</topic><topic>pulmonary</topic><topic>Pulmonary Disease, Chronic Obstructive - chemically induced</topic><topic>Pulmonary Disease, Chronic Obstructive - physiopathology</topic><topic>Risk Factors</topic><topic>Smoking</topic><topic>Tobacco</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baldwin, Gayle Cocita</creatorcontrib><creatorcontrib>Choi, Ruth</creatorcontrib><creatorcontrib>Roth, Michael D.</creatorcontrib><creatorcontrib>Shay, Angela H.</creatorcontrib><creatorcontrib>Kleerup, Eric C.</creatorcontrib><creatorcontrib>Simmons, Michael S.</creatorcontrib><creatorcontrib>Tashkin, Donald P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baldwin, Gayle Cocita</au><au>Choi, Ruth</au><au>Roth, Michael D.</au><au>Shay, Angela H.</au><au>Kleerup, Eric C.</au><au>Simmons, Michael S.</au><au>Tashkin, Donald P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evidence of Chronic Damage to the Pulmonary Microcirculation in Habitual Users of Alkaloidal (“Crack”) Cocaine</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>2002-04-01</date><risdate>2002</risdate><volume>121</volume><issue>4</issue><spage>1231</spage><epage>1238</epage><pages>1231-1238</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><coden>CHETBF</coden><abstract>To evaluate BAL cells obtained from habitual users of alkaloidal (“crack”) cocaine alone or in combination with tobacco, for evidence of cocaine-associated alveolar injury.
Prospective cohort study.
A total of 36 healthy men and women (mean age [SD], 37.5 [7.5] years), including 10 cocaine-only smokers (CS), 6 cocaine-plus-tobacco smokers (CTS), 10 tobacco smokers (TS), and 10 nonsmokers (NS), underwent fiberoptic bronchoscopy and BAL.
Cytospins were prepared from BAL cells and stained with Wright-Giemsa for cell differentials and Gomori's stain for detection of hemosiderin. Endothelin (ET)-1 levels were determined from lavage fluid by enzyme-linked immunosorbent assay.
None of the cocaine users reported episodes of hemoptysis or respiratory distress, and routine spirometry findings were within normal limits in all subjects. While there was little effect on total cell numbers or differential counts, the percentages of hemosiderin-positive alveolar macrophages (AMs) were markedly increased in CS (33.8 ± 8.7% [SEM]) compared to TS and NS (< 2%; p < 0.05). The percentages of hemosiderin-laden AMs were also numerically increased in CTS (11.8 ± 7.8%), but this value was not statistically significant from that of TS or NS. ET-1 levels were significantly increased in the fluid recovered from CS (6.2 ± 0.8 pg/mL) when compared to NS (1.2 ± 0.4 pg/mL) and TS (1.3 ± 0.2 pg/mL) [p < 0.05], while ET-1 levels were elevated to a lesser extent in CTS (2.5 ± 0.6 pg/mL). ET-1 levels correlated with the percentage of hemosiderin-positive AMs when CS were analyzed in conjunction with CTS (r = 0.64; p = 0.0004).
Clinically inapparent alveolar hemorrhage occurs frequently in otherwise healthy crack cocaine smokers and is associated with elevated levels of ET-1, indicative of cocaine-induced pulmonary microvascular injury.</abstract><cop>Northbrook, IL</cop><pub>Elsevier Inc</pub><pmid>11948058</pmid><doi>10.1378/chest.121.4.1231</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-3692 |
ispartof | Chest, 2002-04, Vol.121 (4), p.1231-1238 |
issn | 0012-3692 1931-3543 |
language | eng |
recordid | cdi_proquest_journals_200412000 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adult Biological and medical sciences Bronchoalveolar Lavage Fluid - cytology Bronchoscopy Cell Count Cocaine Cocaine-Related Disorders - physiopathology Crack Cocaine - adverse effects Drug addictions endothelin-1 Enzymes Female Hemoptysis Hemorrhage Hemorrhage - chemically induced Hemorrhage - physiopathology hemosiderin Hemosiderin - metabolism Humans Lung - blood supply macrophages Macrophages, Alveolar - cytology Male Medical sciences Microcirculation - drug effects Microcirculation - physiopathology microvasculature Middle Aged pulmonary Pulmonary Disease, Chronic Obstructive - chemically induced Pulmonary Disease, Chronic Obstructive - physiopathology Risk Factors Smoking Tobacco Toxicology |
title | Evidence of Chronic Damage to the Pulmonary Microcirculation in Habitual Users of Alkaloidal (“Crack”) Cocaine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T09%3A36%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evidence%20of%20Chronic%20Damage%20to%20the%20Pulmonary%20Microcirculation%20in%20Habitual%20Users%20of%20Alkaloidal%20(%E2%80%9CCrack%E2%80%9D)%20Cocaine&rft.jtitle=Chest&rft.au=Baldwin,%20Gayle%20Cocita&rft.date=2002-04-01&rft.volume=121&rft.issue=4&rft.spage=1231&rft.epage=1238&rft.pages=1231-1238&rft.issn=0012-3692&rft.eissn=1931-3543&rft.coden=CHETBF&rft_id=info:doi/10.1378/chest.121.4.1231&rft_dat=%3Cproquest_cross%3E118919489%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=200412000&rft_id=info:pmid/11948058&rft_els_id=S0012369215343051&rfr_iscdi=true |